• Hematology/Oncology - Internal Medicine
• Internal Medicine

• Professor of Medicine Clinical Educator Track

Charles Vogel, MD is a board certified medical oncologist. His clinical and research interests involve all medical aspects of breast cancer treatment including anti-hormonal therapy, chemotherapy and "targeted therapy." During his 35 years of breast cancer research, he has participated in clinical trials of virtually every medical breast cancer treatment currently available. He was one of the clinical trial pioneers in Trastuzumab (Herceptin) therapy and more recently with Bevacizimab (Avastin) and Lapatanib (Tykerb). He was also one of the early pioneers in the development of clinical trials from within community practice. Currently the "Cancer Research Network" he founded has become the community clinical trials outreach program for the University of Miami. Dr. Vogel continues his interest in breast cancer clinical trials both through his involvement with the Breast Site Group of the Sylvester Comprehensive Cancer Center and through similar interactions with community oncologists within the Cancer Research Network.